The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 4, 2013, Pages 554-560

  Hajsadeghi, Shokoufeh ^a   Kashani Amin, Ladan ^a   Bakhshandeh, Hooman ^a   Rohani, Mohammad ^a   Azizian, Amir Reza ^a   Jafarian Kerman, Scott Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

N terminal pro B type natriuretic peptide; stroke; TOAST classification diagnostic value

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; BLOOD; CHI SQUARE DISTRIBUTION; COMPLICATION; DIFFERENTIAL DIAGNOSIS; EMBOLISM; EVALUATION STUDY; HEART DISEASES; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY; STATISTICAL MODEL; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; EMBOLISM; FEMALE; HEART DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; STROKE;

EID: 84877033283     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.01.012     Document Type: Article

References (36)

1. M. Kumar, and S.K. Sarin Biomarkers of diseases in medicine N. Mukunda, Current Trends of Science Platinum Jubilee Special 2009 Indian Academy of Sciences Bangalore, India 403 417
2. S. Hajsadeghi, S.R. Kerman, and M. Khojandi Accuracy of D-dimer:fibrinogen ratio to diagnose pulmonary thromboembolism in patients admitted to intensive care units Cardiovasc J Afr 23 2012 446 456
3. J. Cockburn, M. Behan, and A. de Belder Use of troponin to diagnose periprocedural myocardial infarction: Effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE) Heart 98 2012 1431 1435
4. G.A. Nichols, T.M. Kimes, and J.B. Harp Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes Diabetes Care 35 2012 495 497
5. S. Janda, and J. Swiston Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: A systematic review and meta-analysis BMC Pulm Med 10 2010 58
6. V. Bhalla, S. Willis, and A.S. Maisel B-type natriuretic peptide: The level and the drug-partners in the diagnosis of congestive heart failure Congest Heart Fail 10 1 Suppl 1 2004 3 27
7. G.W. Moe B-type natriuretic peptide in heart failure Curr Opin Cardiol 21 2006 208 214
8. I.H. Kurt, S. Demirkol, and I. Ünal Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: A prospective observational cohort study Anadolu Kardiyol Derg 12 2012 107 114
9. A. Sahinarslan, G. Güz, and R. Mutluay The impact of dialysis type on biomarkers for cardiovascular diseases Turk Kardiyol Dern Ars 39 2011 456 462
10. A. Martínez-Salio, J. Benito-León, and J. Díaz-Guzmán Cerebrovascular disease incidence in central Spain (NEDICES): A population-based prospective study J Neurol Sci 298 2010 85 90
11. R.C. Becker Biomarkers in atrial fibrillation: Investigating biologic plausibility, cause, and effect J Thromb Thrombolysis 19 2005 71 75
12. M. Rodríguez-Yáñez, T. Sobrino, and M. Blanco High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke Dis Markers 26 2009 189 195
13. M. Shimano, R. Shibata, and Y. Tsuji Circulating adiponectin levels in patients with atrial fibrillation Circ J 72 2008 1120 1124
14. A. Choudhury, B. Freestone, and J. Patel Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation. A link among platelet activation, angiogenesis, and thrombosis? Chest 132 2007 1913 1919
15. W. Ageno, S. Finazzi, and L. Steidl Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes Arch Intern Med 162 2002 2589 2593
16. K. Nakagawa, T. Yamaguchi, and M. Seida Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke Cerebrovasc Dis 19 2005 157 164
17. J.R. Lynch, R. Blessing, and W.D. White Novel diagnostic test for acute stroke Stroke 35 2004 57 63
18. K. Iltumur, A. Yavavli, and A. Karabulut Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke Am Heart J 151 2006 1115 1122
19. K. Shibazaki, K. Kimura, and Y. Iguchi Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke Intern Med 48 2009 259 264
20. K. Yukiiri, N. Hosomi, and T. Naya Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke BMC Neurol 8 2008 45
21. T. Naya, K. Yukiiri, and N. Hosomi Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation Cerebrovasc Dis 26 2008 434 440
22. Y. Okada, K. Shibazaki, and K. Kimura Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation J Neurol Sci 301 2011 86 89
23. E. Di Angelantonio, S. De Castro, and D. Toni Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA J Neurol Sci 260 2007 139 142
24. A.M. Mäkikallio, T.H. Mäkikallio, and J.T. Korpelainen Natriuretic peptides and mortality after stroke Stroke 36 2005 1016 1020
25. D.J. Campbell, M. Woodward, and J.P. Chalmers Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease Hypertension 45 2005 69 74
26. Y. Okada, K. Shibazaki, and K. Kimura Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack Eur J Neurol 17 2010 326 331
27. D.J. Campbell, M. Woodward, and J.P. Chalmers Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease Arch Neurol 63 2006 60 65
28. H.P. Adams Jr., R.F. Woolson, and W.R. Clarke Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Control Clin Trials 18 1997 358 377
29. T. Brott, and J. Bogousslavsky Treatment of acute ischemic stroke N Engl J Med 343 2000 710 722
30. P.L. Kolominsky-Rabas, M. Weber, and O. Gefeller Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study Stroke 32 2001 2735 2740
31. K. Bettermann Biomarkers for stroke: In search of fingerprints J Stroke Cerebrovasc Dis 20 2011 173 176
32. K. Hirano, S. Takashima, and N. Dougu Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype J Stroke Cerebrovasc Dis 21 2012 404 410
33. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
34. T. Komori, K. Eguchi, and H. Tomizawa Factors associated with incident ischemic stroke in hospitalized heart failure patients: a pilot study Hypertens Res 31 2008 289 294
35. S. Inoue, Y. Murakami, and K. Sano Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation J Card Fail 6 2000 92 96
36. H. Silvet, Y. Young-Xu, and D. Walleigh Brain natriuretic peptide is elevated in outpatients with atrial fibrillation Am J Cardiol 92 2003 1124 1127